Sarepta Therapeutics, Inc. (LON:0L35)
London · Delayed Price · Currency is GBP · Price in USD 23.56
-0.76 (-3.13%)
At close: Nov 3, 2025
Sarepta Therapeutics Employees
Sarepta Therapeutics had 1,372 employees as of December 31, 2024. The number of employees increased by 58 or 4.41% compared to the previous year.
Employees
1,372
Change (1Y)
58
Growth (1Y)
4.41%
Revenue / Employee
1.32M GBP
Profits / Employee
-30.83K GBP
Market Cap
1.82B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,372 | 58 | 4.41% |
| Dec 31, 2023 | 1,314 | 152 | 13.08% |
| Dec 31, 2022 | 1,162 | 322 | 38.33% |
| Dec 31, 2021 | 840 | -26 | -3.00% |
| Dec 31, 2020 | 866 | 123 | 16.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Sarepta Therapeutics News
- 3 days ago - A Peek at Sarepta Therapeutics's Future Earnings - Benzinga
- 4 days ago - Piper Sandler Maintains Neutral Rating on SRPT, Raises Price Target to $16 | SRPT Stock News - GuruFocus
- 4 days ago - Interesting SRPT Put And Call Options For December 19th - Nasdaq
- 7 days ago - Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results - Business Wire
- 11 days ago - Tradr Launches 9 Single-Stock 2X ETFs With First-Of-Its-Kind OpenDoor, Gold And AI Exposure - Benzinga
- 11 days ago - Tradr Debuts Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF - PRNewsWire
- 24 days ago - Sarepta Therapeutics: A Discounted Valuation Meets Breakthrough Pipeline - Seeking Alpha
- 26 days ago - What's Going On Sarepta Stock On Wednesday? - Benzinga